ǰÑÔ
ÐÄÂÉʧ³£(arrhythmia)ÊÇÁÙ´²×î³£¼ûµÄÐÄѪ¹Ü¼²²¡Ö®Ò»£¬Ö÷ÒªÓÉÓÚÐÄÔ༤¶¯µÄÆðÔ´»ò´«µ¼Òì³£ÒýÆðÐÄÂÉ»òÐÄÂʸı䡣ʵÑéÐÔÐÄÂÉʧ³£¶¯ÎïÄ£×ӵĸ´ÖÆÒªÁìÖ÷ÒªÓÐÒ©ÎïÓÕµ¼¡¢µç´Ì¼¤ºÍ¹Ú×´¶¯Âö½áÔú¡£³£Óõ͝ÎïÓÐСÊó¡¢´óÊó¡¢ëàÊó¡¢¼ÒÍá¢Ã¨¡¢È®ºÍÖíµÈ¡£±¾½Ú¾ÍÐÄÂÉʧ³£ÖнÏΪ³£¼ûµÄÐÄ·¿²ü¶¶£¯ÆË¶¯¡¢·¿ÐÔÐ͝¹ýËÙ¡¢ÊÒÐÔÐ͝¹ýËÙ¡¢ÐÄÊÒ²ü¶¶¡¢²¡Ì¬ ñ¼·¿½á×ÛºÏÕ÷¡¢·¿ÊÒ´«µ¼×èÖ͵ȶ¯ÎïÄ£×Ó¾ÙÐÐÏÈÈÝ¡£
ÐÄ·¿²ü¶¶(atrial fibrillation)ÊÇÁÙ´²ÉÏ×î³£¼ûµÄÐÄÂÉʧ³£ÀàÐÍÖ®Ò»£¬¾ßÓнϸߵķ¢²¡ÂÊ¡¢Ö²ÐÂʺÍÖÂËÀÂÊ¡£·¿²üµÄÐγɿÉÄܱ£´æ¶àÖÖ·¢²¡»úÖÆ¡£ÏÖÔÚÎÄÏ×±¨µÀµÄ·¿²ü¶¶ÎïÄ£×ÓÓжàÖÖ£¬Èç¿ìËÙÐÄ·¿Æð²«Ä£×Ó¡¢ÆÊ½âËðÉËÄ£×Ó¡¢ÎÞ¾úÐÔÐİüÑ×Ä£×Ó¡¢ÃÔ×ßÉñ¾ÐÔ·¿²üÄ£×ӵȣ¬ÒÔ϶ÔÖÆ×÷ÖÖÖÖ·¿²ü¶¶ÎïÄ£×Ó×öÒ»¸ÅÊö¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯ÎȮ¡¢É½Ñò¡¢ÆäËû¶¯Îï
¡¾ÔìÄ£»úÖÆ¡¿£º
¿ìËÙÐÄ·¿Æð²«·¿²üÄ£×ÓÊÇÏÖÔÚÑо¿×î¶à¡¢Ó¦ÓÃ×î¹ãµÄÂýÐÔ·¿²ü¶¶ÎïÄ£×Ó¡£Æä»úÖÆÓë¿ìËÙÐÄ·¿Æð²«¿ÉÒýÆðÐÄ·¿µçÖØ¹¹ºÍ½á¹¹Öع¹Óйء£ÖÖÖÖ¶¯ÎïÄ£×Ó¶¼ÎÞÒ»ÆÆÀýµÄÏÔʾ£ºÐÄ·¿ÓÐÓò»Ó¦ÆÚ(ERP)Ëõ¶Ì£¬ÆµÂÊ˳ӦÐÔϽµ£¬Í¬Ê±°éÓÐÐÄ·¿ÄÚ¾¶¡¢ÈÝ»ýÏÔ×ÅÔö´óµÈ£¬²¢ÔöÌíÁ˸÷ÏòÒìÐÔ£¬Ê¹¶à²¨ÕÛ·µÒ×ÓÚ±¬·¢¡£ÆäÖ÷ÒªµÄÀë×Ó»úÖÆÊÇϵ÷L£Ð͸ƵçÁ÷ICa.L¡¢Ë²Ê±ÍâÏò¼ØµçÁ÷ItoºÍÑÓ³ÙÕûÁ÷µÄ¼ØµçÁ÷IKs¡£
¡¾ÔìÄ£ÒªÁì¡¿£º
¢ÅÈ®£ºÓÿµ½¡³ÉÄêÔÓÖÖÈ®£¬ÌåÖØ16-30kg£¬êòĵ²»ÏÞ¡£ÓÃÎì°Í±ÈÍ×ÄÆ¾²ÂöÂé×í(30mg/kg)¾²Âö×¢Éäºó£¬ÓÃÒì·úÍé(2mg/kg)ºÍ¾²ÂöÂÈÈ©ÌÇ(0.3-0.4mg/ kg)ά³ÖÈ«ÉíÂé×í»ò¼¡ÄÚ×¢ÉäÒÒõ£±ûàº(0.3-0.4mg/ kg)ºóÓÃ4£¥·úÍé¡¢2L/minÑõ»¯Ñǵª¡¢lL/minÑõÆøºÍ2minµÄÒ½ÓÃÆøÌåÎüÈëά³ÖÈ«ÉíÂé×í¡£ÔÚXÏß»úÖ¸ÒýϾ¹É¾²Âö½«6FËļ«µç¼«µ¼¹ÜËÍÈëÓÒÐÄ·¿£¬²â¶¨ÐÄ·¿Æð²«ãÚÖµ¡£¸øÓè400~800´Î£¯minµÄÆð²«ÐÄ·¿£¬ÓÃ2ºÁÃëÂö¿í¡¢2~4±¶ãÚÖµµçѹS1S1(300ºÁÃ룩»òS1S2 (S1S1/S1S2 300ms/200ms£¬²½³¤5ºÁÃëµÝ¼õɨÃ裩³Ì¿Ø´Ì¼¤ÓÕ·¢·¿²ü¡£
¢ÆÉ½Ñò£ºÑ¡ÓÃÌåÖØ15~65kgɽÑò¡£ÓÃÁòÅçÍ×ÄÆ(10mg/kg)¾²Âö×¢ÉäºóÎüÈË·úÍé(1%-2%£©¡¢1 : 2 ÑõÆø£ºÑõ»¯Ñǵª»ìÏýÆøÌåά´ýÈ«ÉíÂé×í¡£×ó²à¿ªÐØ£¬¼ô¿ªÐİü£¬½«µç¼«ÖÃÓÚɽÑòµÄ×ó¡¢ÓÒÐÄ·¿ÐÄÍâĤÓÎÀë±ÚÒÔ¼°BachmannÊø£¬·ìºÏÐØ±Ú£¬½«µç¼«ÓëÌåÍâ×Ô¶¯³ý²üÆ÷ÅþÁ¬£¬¸øÓèÆµÂÊ50Hz¡¢Ê±¼ä1ºÁÃë¡¢¼ä϶20ºÁÃ롢ǿ¶È4±¶ÊæÕÅÆÚ·§ÖµµÄâ§·¢´Ì¼¤¾ÙÐжಿλͬʱ´Ì¼¤£¬Èô·¿²ü±¬·¢£¬Ôò×èÖ¹´Ì¼¤£¬Èô·¿²ü±¬·¢ºóÓÖתΪñ¼ÐÔÐÄÂÉ£¬Ôò´Ì¼¤¼ÌÐø¡£
¢ÇÆäËû¶¯Î¸ÃÄ£×ÓÔÚСÊó¡¢´óÊó¡¢¼ÒÍõȾùÄÜÀֳɸ´ÖÆ£¬¶¯ÎïÂé×íºó£¬½«µç¼«ÖÃÓÚÓÒÐÄ·¿£¬¸øÓè¸ßƵ´Ì¼¤£¬¾ø´ó´ó¶¼¶¯Îï¾ùÄÜÓÕ·¢·¿²üµÄ±¬·¢¡£
¡¾Ä£×ÓÌØµã¡¿£º
¼±ÐÔ¸ßÆµ´Ì¼¤10Ãë¡«30·ÖÖӾͿÉÒÔÓÕ·¢·¿²ü±¬·¢£¬¶ø¸øÓè6~8ÖÜÂýÐÔ¸ßÆµ´Ì¼¤¿É¸´ÖÆ×Ô¾õÐÔ·¿²ü¡£
¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º
¾¿ìËÙÓÒ·¿Æð²«ÒªÁìÖÆ×÷ÐÄ·¿²ü²ü¶¶ÎïÄ£×ÓÀÖ³ÉÂʸߡ¢Öظ´ÐÔºÃÇÒ·¿²üά³Öʱ¼ä½Ï³¤£»¿ÉÓÃÓڷǰêĤÐÔAF·¢²¡»úÖÆ¡¢µçÐÄÀíÖØ¹¹¡¢Ðļ¡Öع¹¡¢·Ö×ÓÉúÎïѧ¸Ä±äµÈÁÙ´²Ñо¿£¬Ò²¿ÉÓÃÓÚÐ͝¹ýËÙÐÔÐ¡¼°²¿·ÖÉñÁ¦Ë¥½ßµÄÑо¿¡£²»¹ýÓø÷¨Ó¦×¢ÖØ¿ØÖÆÐÄÊÒÂÊ£¬ÓÉÓÚ¹ý¿ìµÄÐÄÊÒÂÊ¿ÉÒÔÔì¹ÊÒâÊÒ¹¦Ð§²»È«²¢µ¼ÖÂÓë¿ìËÙÐÄ·¿Æð²«Î޹صÄÐÄ·¿¸Ä±ä¡£
²Î¿¼ÎÄÏ×£º
1.A.rmour JA, Richer LP,Pag P,el al. Origin and pharrnacological response of atrial tachyarrhythmias induced by activation of mediastinal nerves in canines. Auton eurosci, 2005, 118 (1-2):68-78
2.Cheung PH,Pugsley MK,Walker MJ. Arrhythmia models in the rat. J P¹émacol Toxicol Methods, 1993, 29 (4): 179-184
3.Di Diego JM, Anlzelevilch C. Ischemic ventricular arrhy Lhmias: experimental models and their clinical relevance. Heart Rhythm,2011,8(12):1963-1968
4.Hamlin RL. Animal models of ventricular arrhythmias. Pharmacol Ther, 2007, 113(2):276-295
5.Nishida K,Michael G,Dobrev D,el al. Animal models for atrial fibrillation: clinical insights and scientific oppo1tunilies. Europace,2010,12(2):160-172
6.Riley G, Syeda F, Kirchhof P, et al. An introduction lo murine models of alrial fihrillaLion. Front Physio1, 2012, 3: 296
7.Yong SL, Wang QK. Animal models for cardiac arrhytJ1mias. Methods Mol Med,2006, 129: 127-148